Inappropriate therapy for methicillin-resistant Staphylococcus aureus: Resource utilization and cost implications*
暂无分享,去创建一个
[1] 古谷 良輔,et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.
[2] Roberta B Carey,et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.
[3] Scott T. Micek,et al. Before–after study of a standardized hospital order set for the management of septic shock* , 2006, Critical care medicine.
[4] Joshua A. Doherty,et al. Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment* , 2006, Critical care medicine.
[5] Y. Tabak,et al. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia , 2006, Critical care.
[6] R. Gaynes,et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] M. Niederman,et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia , 2006, European Respiratory Journal.
[8] R. Lynfield,et al. Methicillin-resistant Staphylococcus aureus disease in three communities. , 2005, The New England journal of medicine.
[9] M. Kollef,et al. Pseudomonas aeruginosa Bloodstream Infection: Importance of Appropriate Initial Antimicrobial Treatment , 2005, Antimicrobial Agents and Chemotherapy.
[10] S. Cosgrove,et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Daniel J Sexton,et al. Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.
[12] Marin H Kollef,et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. , 2002, Chest.
[13] G Sherman,et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.
[14] D. Sexton,et al. Nosocomial Methicillin-Resistant and Methicillin-Susceptible Staphylococcus Aureus Primary Bacteremia: At What Costs? , 1999, Infection Control & Hospital Epidemiology.
[15] A. Kumar. Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States , 2008 .
[16] P. Appelbaum. MRSA--the tip of the iceberg. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[17] S. Cosgrove,et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.